Droplet digital PCR for diagnosing invasive aspergillosis in hematological malignancies: a prospective cohort study
Journal of Clinical Microbiology · 11.11.2026 · 64 (11)
DOI: 10.1128/jcm.01140-26 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Clinical Microbiology, erschienen am 11.11.2026. Verfasst von Roni Bitterman und 13 weiteren Autor:innen. Beteiligte Einrichtung: Transplant Infectious Diseases, Ajmera Transplant Centre, University Health Network, Toronto, Canada. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Aspergillus, Invasive Pulmonary Aspergillosis, Molecular Diagnostic Techniques. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PSI Foundation.
Abstract (Originalsprache)
Our objective was to evaluate the diagnostic accuracy of Aspergillus droplet digital PCR (ddPCR) in exhaled breath condensate (EBC) and bronchoalveolar lavage fluid (BALF) for diagnosing invasive aspergillosis (IA), and to compare its performance with quantitative real-time PCR (qPCR) in patients with hematologic malignancies. We conducted a prospective single-center study, including adults admitted to leukemia and allogeneic hematopoietic stem cell transplant units who underwent bronchoscopy for pulmonary infiltrates between October 2021 and December 2024. EBC and BALF were collected concurrently. ddPCR was performed on EBC and BALF (supernatant and cell pellet); qPCR was performed on BALF samples. IA was classified according to EORTC/MSGERC criteria without incorporating PCR into the reference standard. Diagnostic performance characteristics, including area under the receiver operating characteristic curve (AUC-ROC), were calculated. Among 203 participants, 26 (12.8%) were diagnosed with probable or proven IA. EBC ddPCR showed poor performance (AUC-ROC 0.55, 95% CI 0.43–0.67). BALF supernatant ddPCR demonstrated the best performance (AUC-ROC 0.88, 95% CI 0.80–0.96), with sensitivity of 0.65 (95% CI 0.43–0.84) and specificity of 0.96 (95% CI 0.92–0.99). BALF supernatant outperformed BALF cell pellet testing for both ddPCR and qPCR. Compared with qPCR, ddPCR showed higher sensitivity and similarly high specificity. Among participants without prior mold-active antifungal therapy, BALF supernatant ddPCR showed improved performance (AUC-ROC 0.95, 95% CI 0.89–1.00). In this large prospective study, EBC ddPCR demonstrated limited utility for the diagnosis of IA. BALF supernatant was the optimal specimen type, and ddPCR outperformed qPCR. Diagnostic performance improved substantially without prior mold-active antifungal exposure. IMPORTANCE Invasive aspergillosis is difficult to diagnose in patients with hematologic malignancies, and non-invasive diagnostic approaches are needed. In this prospective study of 203 patients, Aspergillus droplet digital PCR performed poorly in exhaled breath condensate (area under the receiver operating characteristic curve 0.55; 95% CI 0.43–0.67) but showed good diagnostic performance in bronchoalveolar lavage supernatant fluid (area under the receiver operating characteristic curve 0.88; 95% CI 0.80–0.96). Droplet digital PCR demonstrated higher sensitivity than quantitative PCR with similarly high specificity, and bronchoalveolar lavage supernatant fluid consistently outperformed cell pellet testing. Among patients without prior mold-active antifungal therapy, the area under the receiver operating characteristic curve was 0.95 (95% CI 0.89–1.00). These findings support bronchoalveolar lavage supernatant fluid as the preferred specimen for Aspergillus droplet digital PCR and warrant further evaluation of this approach for diagnosing invasive aspergillosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Transplant Infectious Diseases, Ajmera Transplant Centre, University Health Network, Toronto, Canada.
- Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
- Messner Bone Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
- Department of Laboratory Medicine and Pathology, University Health Network, Toronto, Canada.
ORCID-Profile: Roni Bitterman, Shahid Husain
Förderung
- PSI Foundation
Zitieren
APA
Bitterman, R., Ng, C. F., Arora, S., Casciato, M., Magyar, U., Salazar, S., Usman, N., Pervez, Z., Rehan, F., Walti, L. N., Mattsson, J., Gupta, V., Mazzulli, T., & Husain, S. (2026). Droplet digital PCR for diagnosing invasive aspergillosis in hematological malignancies: a prospective cohort study. Journal of Clinical Microbiology, 64(11). https://doi.org/10.1128/jcm.01140-26
Vancouver
Bitterman R, Ng CF, Arora S, Casciato M, Magyar U, Salazar S, et al. Droplet digital PCR for diagnosing invasive aspergillosis in hematological malignancies: a prospective cohort study. Journal of Clinical Microbiology. 2026;64(11). doi:10.1128/jcm.01140-26
BibTeX
@article{Bitterman2026,
author = {Bitterman, Roni and Ng, Chun Fai and Arora, Simran and Casciato, Milena and Magyar, Ursula and Salazar, Sophia and Usman, Naveen and Pervez, Zohair and Rehan, Farwa and Walti, Laura N and Mattsson, Jonas and Gupta, Vikas and Mazzulli, Tony and Husain, Shahid},
title = {Droplet digital PCR for diagnosing invasive aspergillosis in hematological malignancies: a prospective cohort study},
journal = {Journal of Clinical Microbiology},
year = {2026},
volume = {64},
number = {11},
doi = {10.1128/jcm.01140-26}
}
EUVIMED